Comparing the Manchester procedure versus vaginal hysterectomy for uterine prolapse
Official title: Manchester Procedure Versus Vaginal Hysterectomy for Women With Uterine Prolapse: A Multi-Center Randomized Controlled Study (The Fin-UP Trial)
Run by Tampere University Hospital · NCT07566949 · Data updated 2026-11-12
This study tests whether the Manchester procedure or vaginal hysterectomy works better for women with symptomatic uterine prolapse over a two-year follow-up.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | Women only |
| Enrollment | 426 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 6 sites (Helsinki and 5 other locations) |
| Status | Recruiting |
| Started | May 2026 |
| Main results expected | December 2033 |
| Study ends | December 2041 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT07566949 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women over 18 with symptomatic pelvic organ prolapse stage 2 or higher (uterine descent meeting POP‑Q criteria), fit for elective vaginal surgery, and with no prior POP surgery are the ideal candidates.
✕Probably not a fit
Women planning future pregnancy, those with active or suspected uterine/cervical malignancy, abnormal uterine bleeding, or other contraindications to uterine preservation or vaginal surgery are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Fin-UP trial randomly assigns women with symptomatic uterine prolapse to either the uterus-preserving Manchester procedure or to vaginal hysterectomy with apical suspension in a 1:1 parallel-group design. The primary outcome is a composite success measure at follow-up (no prolapse beyond the hymen, no bulge symptoms, and no retreatment). Secondary outcomes include anatomical results, pelvic floor symptoms, quality of life, sexual function, satisfaction, perioperative parameters, and adverse events. A total of 426 participants will be followed at 1, 2, 5, and 10 years to capture both short- and long-term outcomes.
Why it matters
Potential benefit: If successful, the Manchester procedure could provide a uterus-preserving, less invasive option with similar or better long-term success and faster recovery compared with vaginal hysterectomy.
How similar studies have gone: Existing observational studies suggest short-term advantages for the Manchester procedure, but randomized and long-term comparative evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Fit for elective vaginal surgery according to standard preoperative assessment * Women aged over 18 years * No previous POP surgery * Symptomatic POP stage 2 or higher, with uterine descent of at least stage 2 (POP-Q point C ≥ minus 1) and with POP-Q point D ≤ minus 1. Patients with concurrent anterior or posterior compartment defects will be included. Exclusion Criteria: * Pregnancy or future plans of pregnancy * Active malignancy of any kind * Contraindications for uterine preservation, i.e. suspected cervical or uterine malignancy, abnormal cervical cytology, abnormal uterine bleeding, a history of endometrial hyperplasia with atypia, or a known hereditary cancer syndrome involving the uterus (e.g., Lynch syndrome). All patients will undergo a clinical examination and ultrasound assessment prior to recruitment. If clinically indicated, a Pap-smear and/or endometrial biopsy will be performed prior to inclusion. * Contraindication to vaginal hysterectomy (e.g. extensive intra-abdominal adhesions) * Patient's preference for uterine removal or preservation * Planned concomitant incontinence procedure * Inability to speak Finnish or Swedish, understand the purpose of the study, or commit to follow-up
Where it's running
-
Helsinki University Hospital
Helsinki, Finland Recruiting -
Hospital Nova, The Wellbeing Services County of Central Finland
Jyväskylä, Finland Recruiting -
Kuopio University Hospital
Kuopio, Finland Recruiting -
Oulu University Hospital
Oulu, Finland Recruiting -
Tampere University Hospital
Tampere, Finland Recruiting -
Turku University Hospital
Turku, Finland Recruiting
Study contacts
- Study coordinator: Päivi K Karjalainen, MD, PhD
- Email: paivi.karjalainen@hyvaks.fi
- Phone: +358142695512
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vaginal versus robotic-assisted abdominal mesh repair for apical prolapse
This study will test whether vaginal mesh repair works as well and is as safe as robotic-assisted abdominal mesh repair for women with stage II or higher apical pelvic organ prolapse.
-
Wrist activity tracking to guide early recovery after pelvic organ prolapse surgery
This study will try giving women having pelvic organ prolapse surgery either usual postoperative advice or a guided early-exercise plan while tracking activity with a wrist accelerometer to see which group reaches "mostly recovered" sooner.
-
Deep muscle relaxation and a low-residue diet to improve the surgical view during vNOTES hysterectomy
This trial tests whether a preoperative low-residue diet and deeper muscle relaxation help doctors see better during a vaginally performed hysterectomy for benign conditions.
-
Combined pelvic floor retraining and hypopressive exercises for uterine prolapse outcomes
This study tests whether adding Hypopressive Exercises to Pelvic Floor Functional Movement Retraining helps improve pain, urinary symptoms, and quality of life for women with stage I-II uterine prolapse.
-
Risk predictor for new urinary incontinence after prolapse surgery
This study tests a model to predict which women might develop new stress urinary incontinence after pelvic organ prolapse repair.
-
Poly-L-lactic acid injections for vulvovaginal tissue regeneration
This trial will try injections of poly-L-lactic acid (PLLA) versus placebo to see if they strengthen vaginal tissue and reduce bulge symptoms and sexual problems in women with stage II anterior vaginal wall prolapse (cystocele).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.